Kaplan-Meier survival analysis from the GEPIA data analysis platform showed that cervical cancer patients with high NAT10 expression had poorer Disease-free survival (DFS) compared to cervical cancer patients with low NAT10 expression, indicating that NAT10 expression was negatively associated with DFS for cervical cancer patients (Fig. 1E). Here, NAT10 is linked to cervical cancer.